Dr Mark Christopher Reiner, MD | |
500 S Maple St, Waconia, MN 55387-1752 | |
(952) 442-2191 | |
Not Available |
Full Name | Dr Mark Christopher Reiner |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 15 Years |
Location | 500 S Maple St, Waconia, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124255880 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 56219 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ridgeview Medical Center | Waconia, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Metropolitan Anesthesia Network Llp | 5698689123 | 647 |
News Archive
Here's a sobering fact for millions of young women heading back to school: The more alcohol they drink before motherhood, the greater their risk of future breast cancer.
ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company's proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.
Diverse local authority policies and practices throughout the UK are making big differences to the uptake and operation of 'direct payments' - a system for supporting people who are receiving community care by enabling them to 'purchase' their own care.
Scientists at Dana-Farber Cancer Institute report they have blocked the development of prostate tumors in cancer-prone mice by knocking out a molecular unit they describe as a "powerhouse" that drives runaway cell growth.
› Verified 3 days ago
Entity Name | Metropolitan Anesthesia Network Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558314427 PECOS PAC ID: 5698689123 Enrollment ID: O20031118000579 |
News Archive
Here's a sobering fact for millions of young women heading back to school: The more alcohol they drink before motherhood, the greater their risk of future breast cancer.
ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company's proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.
Diverse local authority policies and practices throughout the UK are making big differences to the uptake and operation of 'direct payments' - a system for supporting people who are receiving community care by enabling them to 'purchase' their own care.
Scientists at Dana-Farber Cancer Institute report they have blocked the development of prostate tumors in cancer-prone mice by knocking out a molecular unit they describe as a "powerhouse" that drives runaway cell growth.
› Verified 3 days ago
Entity Name | Ridgeview Anesthesia Assoc, P.a. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083719215 PECOS PAC ID: 4385650803 Enrollment ID: O20060221000612 |
News Archive
Here's a sobering fact for millions of young women heading back to school: The more alcohol they drink before motherhood, the greater their risk of future breast cancer.
ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company's proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.
Diverse local authority policies and practices throughout the UK are making big differences to the uptake and operation of 'direct payments' - a system for supporting people who are receiving community care by enabling them to 'purchase' their own care.
Scientists at Dana-Farber Cancer Institute report they have blocked the development of prostate tumors in cancer-prone mice by knocking out a molecular unit they describe as a "powerhouse" that drives runaway cell growth.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Mark Christopher Reiner, MD 500 S Maple St, Waconia, MN 55387-1752 Ph: (952) 442-2191 | Dr Mark Christopher Reiner, MD 500 S Maple St, Waconia, MN 55387-1752 Ph: (952) 442-2191 |
News Archive
Here's a sobering fact for millions of young women heading back to school: The more alcohol they drink before motherhood, the greater their risk of future breast cancer.
ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company's proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.
Diverse local authority policies and practices throughout the UK are making big differences to the uptake and operation of 'direct payments' - a system for supporting people who are receiving community care by enabling them to 'purchase' their own care.
Scientists at Dana-Farber Cancer Institute report they have blocked the development of prostate tumors in cancer-prone mice by knocking out a molecular unit they describe as a "powerhouse" that drives runaway cell growth.
› Verified 3 days ago
Jule R Block, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-7015 Fax: 952-442-7016 | |
Paul J Savaryn, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-7015 Fax: 952-442-7016 | |
John A Hill, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-7015 Fax: 952-442-7016 | |
John H Merideth Jr., MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 29 E Main St, Waconia, MN 55387 Phone: 952-442-7015 Fax: 952-442-7016 | |
Igor P Ostanny, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-7015 Fax: 952-442-7016 | |
James M Turner, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-7015 Fax: 952-442-7016 |